Grazoprevir and Elbasvir in Patients with Genotype 1 Hepatitis C Virus Infection: A Comprehensive Efficacy and Safety Analysis

Background. It is urgent for patients with hepatitis C virus (HCV) infection to find a safe, effective, and interferon-free regimen to optimize therapy. A comprehensive analysis was performed to evaluate the efficacy and safety of the grazoprevir combined with elbasvir, with or without ribavirin (RB...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Can J Gastroenterol Hepatol
Autors principals: Yao, Yinan, Yue, Ming, Wang, Jie, Chen, Hongbo, Liu, Mei, Zang, Feng, Li, Jun, Zhang, Yun, Huang, Peng, Yu, Rongbin
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5253517/
https://ncbi.nlm.nih.gov/pubmed/28164081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8186275
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars